Sonic Incytes is proudly presenting at the Canadian Liver Meeting, February 28 to March 1, 2020, in Montreal, Canada. Join us at our poster presentation to learn about our promising initial results in assessing fibrosis and steatosis with our breakthrough, point of care ultrasound solution.
We recognize that healthcare practitioners need a better tool to routinely assess and manage those with identified risk factors for chronic liver disease. VelacurTM is the first handheld 3D liver health assessment tool that is fast, accurate and intelligent. It provides a clear picture of the liver in real time, so you can be confident in your diagnosis, treatment and care.
Interested to find out more? Contact us at info@www.sonicincytes.com.
